2) hemostatic
[英][,hi:mə'stætik] [美][,himə'stætɪk]
止血药
1.
Study on the stability of mixture of gatifloxacin with other three kinds of hemostatics in 5% glucose injection;
加替沙星与3种止血药在5%葡萄糖注射液中的稳定性考察
2.
Application of Hemostatics during Operations of Obstetrics;
止血药物在产科围手术期的应用
3.
Study on compatible stability of levofloxicin hydrochloride injection with five kinds of hemostatic;
盐酸左氧氟沙星注射液与五种止血药配伍的稳定性考察
3) plasma concentration
血药浓度
1.
Effectiveness and safety of rifaximin capsule in the treatment of acute infectious diarrhea and determination its plasma concentration;
利福昔明胶囊对急性感染性腹泻的疗效和安全性及其血药浓度测定
2.
Study of rabbit plasma concentration of rifampicin suppositories by UV-visible assay;
紫外-可见分光光度法测定利福平栓剂在家兔体内的血药浓度
3.
Effect of acetylspiramycin on plasma concentration of baicalin in rats;
乙酰螺旋霉素对黄芩苷血药浓度的影响
4) Hematinic
[英][,hemə'tinik] [美][,himə'tɪnɪk]
补血药
1.
Determination and Analysis of Trace Element Proportional Relationship in Medea and Hematinic;
壮阳药与补血药中微量元素比例关系的测定与分析
5) blood concentration
血药浓度
1.
Monitoring blood concentration of cyclosoprine A in renal transplant recipients;
肾移植术后患者环孢素A血药浓度的监测
2.
Clinical study of the blood concentration monitoring for ciclosporin in renal transplant recipient with functional renal allograft more than five years;
5a以上肾移植患者环孢素血药浓度监测的临床分析
3.
Analysis of cyclosporine A blood concentration monitoring in renal transplantation recipients;
肾移植受者环孢素A血药浓度监测情况分析
6) blood drug concentration
血药浓度
1.
Software development of blood drug concentration monitoring system and its application in data analysis;
血药浓度监测系统软件研制及其数据分析的应用
2.
Results:After oral Zhi Gancao Decoction,the blood drug concentration peak time is about 1.
结果 :炙甘草汤口服后的血药浓度达峰时间约为 1 5h左右。
3.
OBJECTIVE:To develop the data processing program of Digoxin blood drug concentration(DBDP)and to determine the range of effective blood concentration of Digoxin.
目的 :开发地高辛血药浓度数据处理 (DBDP)程序 ,确定地高辛有效血药浓度范围。
补充资料：促凝血药
分子式：
CAS号：
性质：促进血液凝固的药物，用于防治因凝血因子缺乏或功能异常所引起的疾病。抗血友病球蛋白浓缩制剂主要用于补充凝血因子Ⅷ和Ⅸ；DDAVP(1-脱氨δ-d-精氨酸-血管加压素)有促进凝血因子Ⅷ释放的作用；维生素K主要用于纠正凝血因子Ⅱ的功能，促进凝血酶复合物(包含因子II、VII、IX、X)的生成。此外，凝血酸、对羧基苄胺等也有促凝血的作用。
CAS号：
性质：促进血液凝固的药物，用于防治因凝血因子缺乏或功能异常所引起的疾病。抗血友病球蛋白浓缩制剂主要用于补充凝血因子Ⅷ和Ⅸ；DDAVP(1-脱氨δ-d-精氨酸-血管加压素)有促进凝血因子Ⅷ释放的作用；维生素K主要用于纠正凝血因子Ⅱ的功能，促进凝血酶复合物(包含因子II、VII、IX、X)的生成。此外，凝血酸、对羧基苄胺等也有促凝血的作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条